Diagnostics
Diagnostics companies are building the infrastructure precision medicine runs on. The product to launch, the channel to lead with, the indication to anchor a development pipeline, the category to enter next, the growth strategy when the core market matures — these are the decisions that determine where a Dx company wins, how it reaches its market, and which categories are worth building for.

Select Capabilities
Product Specification Mapping
Your product doesn’t need to be competitive today – it needs to be competitive in the years to come. We understand the constraints and tradeoffs that are required in product development, and how that impacts market opportunity. DeciBio has the qualitative and quantitative tools to ensure you develop the optimal product for your target customers.
Selected Work

RNA-based Oncology Biomarker Market Landscape
Voice-of-Customer Research
Competitive Analysis
Biomarker and Diagnostics Strategy
Product Specification Mapping

Opportunity Assessment & Target Customer Identification for In-House Hereditary Cancer Testing
Customer Segmentation
Voice-of-Customer Research
Market Landscaping and Sizing

NIPT Market Landscape and Strategy
Voice-of-Customer Research
Competitive Analysis
Customer Segmentation
Go-to-Market Strategy






.png)
.png)



